Alvotech Hf competitive analysis

Explore patent oppositions filed by Alvotech Hf against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALSAug 26, 2026
Multiple-Variable Dose Regimen For Treating Tnfalpha-Related DisordersABBOTT BIOTECHNOLOGYJul 15, 2021
Methods Of Administering Anti-Tnfalpha AntibodiesABBVIE BIOTECHNOLOGYJul 15, 2021

Latest PTAB cases involving Alvotech Hf

Discover the latest PTAB cases involving Alvotech Hf, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Alvotech Hf with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALVOTECH HF3 - - -
ABBOTT BIOTECHNOLOGY - 26 - -
ABBVIE BIOTECHNOLOGY - 41 - 22
REGENERON PHARMACEUTICALS55153932